Patent: 6,448,231
✉ Email this page to a colleague
Summary for Patent: 6,448,231
Title: | Method and compositions for the treatment of cerebral palsy |
Abstract: | The invention provides for the use of a presynaptic neurotoxin (for example a bacterial neurotoxin such as botulinum toxin B) for the manufacture of a medicament for the treatment of cerebral palsy in juvenile patients. The juvenile patients are preferably juveniles of up to 6 years in age. |
Inventor(s): | Graham; Herbert Kerr (Lisburn, GB) |
Assignee: | Allergan, Inc. (Irvine, CA) |
Application Number: | 09/900,380 |
Patent Claims: | see list of patent claims |
Details for Patent 6,448,231
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Solstice Neurosciences, Llc | MYOBLOC | rimabotulinumtoxinb | Injection | 103846 | 12/08/2000 | ⤷ Try a Trial | 2011-09-24 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |